Parag Bawaskar
LightNews LightNews
banner
paragbawaskar.bsky.social
Parag Bawaskar
@paragbawaskar.bsky.social
600 followers 130 following 16 posts
Cardiologist, Post Doctoral Research Associate, Cardiovascular Division, University of Minnesota Medical School.
Posts Replies Media Videos
Pinned
paragbawaskar.bsky.social
Parag Bawaskar @paragbawaskar.bsky.social · Nov 11
Have you ever wondered whether your patient with CAD and cardiomyopathy truly has ischemic cardiomyopathy, or whether the CAD is a “bystander”?

You might be interested in our paper now out in Circulation

#simultaneouspublication
#AHA23
#cardiosky
#Medsky
#WhyCMR
Reposted by Parag Bawaskar
cshenoy.bsky.social
Thank you, @toddneale.bsky.social, for your excellent reporting on our EHJ paper!

@tctmd.bsky.social @escardio.bsky.social @paragbawaskar.bsky.social
June 11, 2025 at 10:12 PM
Reposted by Parag Bawaskar
mugander.bsky.social
Query sarcoid, normal #WhyCMR, so then should we do FDG-PET? Not much benefit.
cshenoy.bsky.social Chetan Shenoy @cshenoy.bsky.social · Mar 21
In patients with suspected cardiac sarcoidosis, cardiac FDG-PET is recommended after a normal CMR if there is a high clinical suspicion. What are the data supporting this recommendation? #CardioSky #MedSky #Sarcoidosis
March 23, 2025 at 5:29 AM
Reposted by Parag Bawaskar
cshenoy.bsky.social
Read our accompanying editorial for our thoughts on the important paper –

academic.oup.com/ehjcimaging/...

@paragbawaskar.bsky.social #CardioSky #MedSky #Sarcoidosis
Cardiac FDG-PET imaging in patients with suspected cardiac sarcoidosis and no late gadolinium enhancement on cardiovascular magnetic resonance imaging: the emperor has no clothes!
This editorial refers to ‘The Role of FDG PET/CT in Assessing Cardiac Sarcoidosis with No High-Risk Cardiac Features and Normal CMR’, by F. Shuduyeva et al
academic.oup.com
March 21, 2025 at 11:39 PM
Reposted by Parag Bawaskar
cshenoy.bsky.social
In patients with suspected cardiac sarcoidosis, cardiac FDG-PET is recommended after a normal CMR if there is a high clinical suspicion. What are the data supporting this recommendation? #CardioSky #MedSky #Sarcoidosis
March 21, 2025 at 11:39 PM
Reposted by Parag Bawaskar
cshenoy.bsky.social
This paper reports the coexistence of cardiac sarcoidosis and arrhythmogenic cardiomyopathy in 5 patients.

heart.bmj.com/content/earl...

#CardioSky #MedSky
Coexistence of cardiac sarcoidosis and arrhythmogenic cardiomyopathy-associated genetic variants: a multicentre case-control study
Background Cardiac sarcoidosis (CS) is a chronic inflammatory disease characterised by non-caseating granulomas, while arrhythmogenic cardiomyopathy (ACM) is a genetic condition mainly affecting desmo...
heart.bmj.com
January 23, 2025 at 2:08 AM
Reposted by Parag Bawaskar
pnatarajanmd.bsky.social
In honor of Dr. Braunwald’s 95th birthday. The number of areas he has touched in cardiology is staggering, and number of cardiovascular professionals is unquantifiable. @harvardmed.bsky.social
November 23, 2024 at 6:26 PM
Reposted by Parag Bawaskar
cshenoy.bsky.social
Amazing achievement by rising star and post-doc in my lab @paragbawaskar.bsky.social, winner of the prestigious 2024 Melvin Judkins Early Career Investigator Award at #AHA24!! Congratulations!!!
@ahascience.bsky.social
November 17, 2024 at 3:46 PM
Reposted by Parag Bawaskar
load-dependent.bsky.social
It’s great that journals are coming over here, but what I have really missed after my departure from Twitter 2 years ago is this, the authors themselves presenting their works and discussing it with peers. #cardiosky #medsky #emimcc
cshenoy.bsky.social Chetan Shenoy @cshenoy.bsky.social · Nov 12
In 2019, we wrote a paper showing that patients with left ventricular thrombus have a long-term risk of embolism, extending to at least 8 years.

We were puzzled by the finding…

#CardioSky

www.ahajournals.org/doi/10.1161/...
Figure 2 from the paper. Incidence of embolism in left ventricular (LV) thrombus patients compared with matched non-LV thrombus patients. Kaplan-Meier curves demonstrate the cumulative incidence of the composite embolic end point in the LV thrombus (in red) and in the matched non-LV thrombus (in blue) groups. Note the significant difference in the cumulative incidence of embolic events between the 2 groups.
November 13, 2024 at 3:58 PM
Reposted by Parag Bawaskar
cshenoy.bsky.social
In 2019, we wrote a paper showing that patients with left ventricular thrombus have a long-term risk of embolism, extending to at least 8 years.

We were puzzled by the finding…

#CardioSky

www.ahajournals.org/doi/10.1161/...
Figure 2 from the paper. Incidence of embolism in left ventricular (LV) thrombus patients compared with matched non-LV thrombus patients. Kaplan-Meier curves demonstrate the cumulative incidence of the composite embolic end point in the LV thrombus (in red) and in the matched non-LV thrombus (in blue) groups. Note the significant difference in the cumulative incidence of embolic events between the 2 groups.
November 12, 2024 at 7:34 PM
paragbawaskar.bsky.social
Have you ever wondered whether your patient with CAD and cardiomyopathy truly has ischemic cardiomyopathy, or whether the CAD is a “bystander”?

You might be interested in our paper now out in Circulation

#simultaneouspublication
#AHA23
#cardiosky
#Medsky
#WhyCMR
November 11, 2023 at 4:09 AM